AAAAAA
Results:
1-14
|
Results: 14
Authors:
Toungouz, M
Libin, M
Bulte, F
Faid, L
Lehmann, F
Duriau, D
Laporte, M
Gangji, D
Bruyns, C
Lambermont, M
Goldman, M
Velu, T
Citation: M. Toungouz et al., Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumors, J LEUK BIOL, 69(6), 2001, pp. 937-943
Authors:
Clement, N
Avalosse, B
El Bakkouri, K
Velu, T
Brandenburger, A
Citation: N. Clement et al., Cloning and sequencing of defective particles derived from the autonomous parvovirus minute virus of mice for the construction of vectors with minimal cis-acting sequences, J VIROLOGY, 75(3), 2001, pp. 1284-1293
Authors:
Demols, PF
Cochaux, PM
Velu, T
Caspers-Velu, L
Citation: Pf. Demols et al., Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus, BR J OPHTH, 85(1), 2001, pp. 93-95
Authors:
Velu, T
Toungouz, M
Faid, L
Libin, M
Lehmann, F
Laporte, M
Vereecken, P
Gangji, D
Bruyns, C
Lambermont, M
Goldman, M
Citation: T. Velu et al., Immunotherapy using dendritic cells, EUR CYTOKIN, 11(2), 2000, pp. 306-308
Authors:
Tenenbaum, L
Jurysta, F
Stathopoulos, A
Puschban, Z
Melas, C
Hermens, WTJMC
Verhaagen, J
Pichon, B
Velu, T
Levivier, M
Citation: L. Tenenbaum et al., Tropism of AAV-2 vectors for neurons of the globus pallidus, NEUROREPORT, 11(10), 2000, pp. 2277-2283
Authors:
Grignet-Debrus, C
Cool, V
Baudson, N
Degreve, B
Balzarini, J
De Leval, L
Debrus, S
Velu, T
Calberg-Bacq, CM
Citation: C. Grignet-debrus et al., Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2 '-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressingeither the Varicella zoster or the Herpes simplex virus thymidine kinase, CANC GENE T, 7(2), 2000, pp. 215-223
Authors:
Grignet-Debrus, C
Cool, V
Baudson, N
Velu, T
Calberg-Bacq, CM
Citation: C. Grignet-debrus et al., The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella tester and Herpes simplex viral thymidine kinases in suicide gene therapy, CANC GENE T, 7(11), 2000, pp. 1456-1468
Authors:
Willermain, F
Caspers-Velu, L
Baudson, N
Dubois, C
Hamdane, M
Willems, F
Velu, T
Bruyns, C
Citation: F. Willermain et al., Role and expression of CD40 on human retinal pigment epithelial cells, INV OPHTH V, 41(11), 2000, pp. 3485-3491
Authors:
Toungouz, M
Quinet, C
Thille, E
Fourez, S
Pradier, O
Delville, JP
Velu, T
Lambermont, M
Citation: M. Toungouz et al., Generation of immature autologous clinical grade dendritic cells for vaccination of cancer patients, CYTOTHERAPY, 1(6), 1999, pp. 447-453
Authors:
El Bakkouri, K
Clement, N
Velu, T
Brandenburger, A
Citation: K. El Bakkouri et al., Amplification of MVM(p) vectors through serial infection of a new packaging cell line, TUMOR TARG, 4(4), 1999, pp. 210-217
Authors:
Brandenburger, A
Coessens, E
El Bakkouri, K
Velu, T
Citation: A. Brandenburger et al., Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors, HUM GENE TH, 10(7), 1999, pp. 1229-1238
Authors:
Tenenbaum, L
Hamdane, M
Pouzet, M
Avalosse, B
Stathopoulos, A
Jurysta, F
Rosenbaum, C
Hanemann, CO
Levivier, M
Velu, T
Citation: L. Tenenbaum et al., Cellular contaminants of adeno-associated virus vector stocks can enhance transduction, GENE THER, 6(6), 1999, pp. 1045-1053
Authors:
Leclercq, V
Hamdane, M
Bruyns, C
Faid, L
Gangji, D
Velu, T
Citation: V. Leclercq et al., Gene immunotherapy of cancer: overview and perspectives, M S-MED SCI, 15(5), 1999, pp. 635-644
Authors:
Donckier, V
Vereecken, P
Blocklet, D
Laporte, M
Velu, T
Heenen, M
Van Geertruyden, J
Citation: V. Donckier et al., Sentinel lymph node mapping in the management of high risk malignant melanoma, ACT CHIR B, 99(6), 1999, pp. 295-298
Risultati:
1-14
|